Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-14-028066

Director bought 18,869 shares at $7.00 ($132,083)

  • Director acquired 41,438 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

RASTETTER WILLIAM H · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2014-04-15 Conversion : show line 1 in the form +7,106 7,106 D
2014-04-15 Conversion : show line 2 in the form +2,576 9,682 D
2014-04-15 Conversion : show line 3 in the form +5,868 15,550 D
2014-04-15 Conversion : show line 4 in the form +8,199 23,749 D
2014-04-15 Conversion : show line 5 in the form +7,589 31,338 D
2014-04-15 Conversion : show line 6 in the form +4,954 36,292 D
2014-04-15 Conversion : show line 7 in the form +5,146 41,438 D
2014-04-15 Purchase : show line 8 in the form +18,869 $7.00 $132,083 60,307 I
Open-market purchases · 18,869 sh · avg $7.00 · $132,083

Table II: Derivative

9 lines
Date Transaction Shares Owned after D/I
2014-04-15 Conversion : show line 9 in the form Series A Convertible Preferred Stock −76,923 0 D
2014-04-15 Conversion : show line 10 in the form Series B Convertible Preferred Stock −22,801 0 D
2014-04-15 Conversion : show line 11 in the form Series B-1 Convertible Preferred Stock −31,500 0 D
2014-04-15 Conversion : show line 12 in the form Series C Convertible Preferred Stock −118,954 0 D
2014-04-15 Conversion : show line 13 in the form Series D Convertible Preferred Stock −110,107 0 D
2014-04-15 Conversion : show line 14 in the form 7% Convertible Promissory Notes −0 0 D
2014-04-15 Conversion : show line 15 in the form 7% Convertible Promissory Notes −0 0 D
2014-04-15 Other disposition : show line 16 in the form Warrant to purchase Series C −5,522 0 D
2014-04-15 Other acquisition : show line 17 in the form Warrant to purchase Series C +380 380 D
Loading xslF345X03/doc4.xml…